Trial NCT02106364

View at ClinicalTrials.gov 
Org. Study IDs: 13564
Secondary IDs: I2R-MC-BIDB

Last trial update was posted on 2016-03-28

MeSH Interventions

Insulin Insulin Glargine Insulin, Globin Zinc

MeSH Conditions

Diabetes Mellitus Diabetes Mellitus, Type 2

Other Conditions


Stopping Reasons

Lilly's decision to cancel this trial is due to regulatory uncertainty in China.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID